Monday, April 23, 2012

SunTrust Banks (STI) q1 significant rise, ConocoPhillips (COP) q1 decline in earnings

Daily forex news and stock for picks today we starts From Banking sector, we reported SunTrust Banks q1 beats view, SunTrust Banks Inc. (STI) on Monday reported a significant rise in first-quarter profit, breezing past expectations, on continued improvement in core business fundamentals. Revenue grew 3 percent and came in above Street view

From Hasbro posts q1 loss, Hasbro Inc. (HAS) reported Monday a loss for the first quarter, hurt by severence costs and lower revenue. The toy maker's results missed consensus

ConocoPhillips q1 profit dips, Monday, ConocoPhillips (COP) posted a decline in earnings for the first quarter, reflecting lower production volumes and refining margins. Adjusted earnings per share rose from last year, but missed Street predictions.

Latest news from D.R. Horton q2 results surpass view, D.R. Horton, Inc. (DHI) said Monday it expects stronger closings and profitability in the second half, while it reported higher-than-expected results for the second quarter

Meanwhile, Kellogg lowers FY12 outlook, Kellogg Co.(K)on Monday slashed its full-year outlook, after a weaker-than-expected first quarter performance, on back of a declining volume growth in certain US categories and its European business.
Another big corporation Nestle SA to buy infant nutrition business from Pfizer, Swiss food giant Nestle SA (NSTR.L, NSRGY.PK) agreed on Monday to buy Pfizer Inc.'s (PFE) infant nutrition business for $11.85 billion in cash. Nestle expects the deal to add to earnings per share from the first year

Latest news from Vodafone, Vodafone To purchase Cable & Wireless Worldwide for 38p/shr, Vodafone Group Plc (VOD, VOD.L) agreed to buy troubled UK telecoms group Cable & Wireless Worldwide Plc (CW.L) for 38 pence per share or 1.04 billion pounds in cash

The biggest AstraZeneca To acquire Ardea Biosciences, Pharmaceutical giant AstraZeneca Plc (AZN, AZN.L) on Monday agreed to buy U.S. gout drug developer Ardea Biosciences Inc. (RDEA) for $1.26 billion. The offer price of $32 per share represents a 54 percent premium on Ardea's closing share price on Friday

No comments:

Post a Comment